Advancing hybrid trials: Medidata contributes global perspectives and insights to new SCRI whitepaper in Singapore
Singapore, Nov. 17 -- Medidata, a Dassault Systemes brand and provider of clinical trial solutions to the life sciences industry, has contributed insights to a newly published whitepaper by the Singapore Clinical Research Institute (SCRI). The paper, titled "Advancing Clinical Trials with Decentralised Elements in Singapore: Opportunities, Readiness, and Scalable Adoption," assesses Singapore's readiness for clinical trials with decentralised elements and outlines a roadmap for their responsible, scalable adoption.
Drawing on its experience supporting more than 42,000 global trials and 13 million patients, Medidata contributed global perspectives and practical insights to the whitepaper's assessment of Singapore's current ecosystem readi...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.